Confo Therapeutics
Richa Virmani is currently employed at Confo Therapeutics as a Scientist, following their previous role as an Associate Scientist at the same company. Prior to this, Richa worked as a Postdoctoral Researcher at Delhi University, where Richa focused on the role of post translational modifications in bacterial spore germination. Richa holds a PhD from Delhi Technological University and also a Research Associate degree from the Institute of Genomics and Integrative Biology (CSIR).
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.